Show simple item record

dc.contributor.authorPrinsloo, Izak F.
dc.contributor.authorZuma, Nonkululeko H.
dc.contributor.authorAucamp, Janine
dc.contributor.authorN'Da, David D.
dc.date.accessioned2020-10-01T08:23:12Z
dc.date.available2020-10-01T08:23:12Z
dc.date.issued2020
dc.identifier.citationPrinsloo, I.F. et al. 2020. Synthesis and in vitro antileishmanial efficacy of novel quinazolinone derivatives. Chemical biology and drug design, (In press). [ https://doi.org/10.1111/cbdd.13790]en_US
dc.identifier.issn1747-0277
dc.identifier.issn1747-0285 (Online)
dc.identifier.urihttp://hdl.handle.net/10394/35834
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/full/10.1111/cbdd.13790
dc.identifier.urihttps://doi.org/10.1111/cbdd.13790
dc.description.abstractCurrently available drugs being used to treat leishmaniasis have several shortcomings, including high toxicity, drug administration that requires hospitalization, and the emergence of parasite resistance against clinically used drugs. As a result, there is a dire need for the development of new antileishmanial drugs that are safe, affordable, and efficient. In this study, two new series of synthesized quinazolinone derivatives were investigated as potential future antileishmanial agents, by assessing their activities against the Leishmania (L.) donovani and L. major species. The cytotoxicity profiles of these derivatives were assessed in vitro on Vero cells. The compounds were found to be safer and without any toxic activities against mammalian cells, compared to the reference drug, halofuginone, a clinical derivative of febrifugine. However, they had demonstrated poor antileishmanial growth inhibition efficacies. The two compounds that had been found the most active were the mono quinazolinone 2d and the bisquinazolinone 5b with growth inhibitory efficacies of 35% and 29% for the L. major and L. donovani 9515 promastigotes, respectively. These outcomes had suggested structural redesign, inter alia the inclusion of polar groups on the quinazolinone ring, to potentially generate novel quinazolinone derivatives, endowed with effective antileishmanial potentialen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.subjectFebrifugineen_US
dc.subjectHalofuginoneen_US
dc.subjectLeishmaniasisen_US
dc.subjectPromastigoteen_US
dc.subjectQuinazolinoneen_US
dc.titleSynthesis and in vitro antileishmanial efficacy of novel quinazolinone derivativesen_US
dc.typeArticleen_US
dc.contributor.researchID20505698 - Aucamp, Janine
dc.contributor.researchID20883072 - N'Da, David Dago
dc.contributor.researchID23978538 - Zuma, Nonkululeko Hazel
dc.contributor.researchID24912085 - Prinsloo, Izak F.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record